Ashley A. Leech

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies

Ashley A. Leech, David D. Kim, Joshua T. Cohen et al. · Value in Health · 2018 · 179 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial

Ian Goodyer, Bernadka Dubicka, Paul Wilkinson et al. · Health Technology Assessment · 2008 · 149 citations · Full text

Education, Pharmacotherapy, Psychiatry +15

Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder

Stephen W. Patrick, Michael R. Richards, William D. Dupont et al. · JAMA Network Open · 2020 · 136 citations · Full text

Medicine, Maternal Health, Obstetrics +15

HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women

Jeanne Marrazzo, Tao Li, Marissa Becker et al. · JAMA · 2024 · 74 citations · Full text

Public Health, Pharmacotherapy, Preventive Medicine +17

Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions

Pei‐Jung Lin, Brittany D’Cruz, Ashley A. Leech et al. · PharmacoEconomics · 2019 · 65 citations · Full text

Medicine, Geriatric Medicine, Cost-effectiveness Analysis +16